Showing results (151-160 of 224) with videos related to
Sort By:
Pageof 23
Biotechnology Healthcare|February 12, 2013
Surrogate markers of efficacy for medical treatment of viral hepatitisTimothy M Block, W Thomas LondonBiotechnology Healthcare|February 12, 2013
Pharmacogenomics: where will it take us?Linda Hull FelconeBiotechnology Healthcare|February 12, 2013
Biotech injectable drugs: clinical applications and financial effectsF Randy Vogenberg, Coleen YoungBiotechnology Healthcare|October 24, 2012
Will comparative effectiveness research finally succeed?Erwin A Blackstone, Joseph P Fuhr, Danielle ZiernickiBiotechnology Healthcare|April 6, 2012
The biologic finance and access council 2nd annual biologics healthcare survey: views from key healthcare stakeholders, part 2David B Nash, Michael Toscani, F Randy VogenbergBiotechnology Healthcare|April 6, 2012
How Will Biologics Fit Into Healthcare Reform?: With so many variables, it's hard to predict what kind of market will exist for biologics and other specialty drugs in 2014. Current trends may provide some insightMichael D DalzellBiotechnology Healthcare|April 6, 2012
Employers Struggle To Cope With the Rising Use of Biologics: Tradeoffs in cost sharing or higher deductibles could derail treatment and decrease the value of healthcare spendingLola ButcherPageof 23